Drug Resistant Epilepsy
Information
- Disease name
- Drug Resistant Epilepsy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03529045 | Active, not recruiting | Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. | February 5, 2018 | April 30, 2025 | |
| NCT04457687 | Available | Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies | |||
| NCT03676049 | Available | Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use) | |||
| NCT05809349 | Completed | N/A | The Mechanism of cTBS Targeting Dentate Nucleus for DRE | April 1, 2023 | December 31, 2023 |
| NCT03419000 | Completed | N/A | Circulating microRNAs as Biomarkers of RESPIratory Dysfunction in Patients With Refractory epilePSY | March 16, 2018 | March 31, 2022 |
| NCT03443388 | Completed | N/A | Novel Helmet Design in Patients With Seizures | August 14, 2017 | March 20, 2020 |
| NCT04378075 | Completed | Phase 2/Phase 3 | A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy | September 28, 2020 | December 27, 2023 |
| NCT06432231 | Completed | N/A | Effects of Low Glycemic Index Diet in Children With Drug-resistant Epilepsy | August 28, 2022 | February 20, 2024 |
| NCT03860298 | Completed | N/A | Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy | June 17, 2019 | October 14, 2020 |
| NCT02982824 | Completed | N/A | Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy | September 2016 | March 2017 |
| NCT05697887 | Completed | N/A | Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam | June 1, 2019 | October 31, 2021 |
| NCT06341075 | Enrolling by invitation | N/A | Real-World Study of Magnetic Resonance-guided Laser Interstitial Thermal Therapy for Drug-resistant Epilepsy | March 14, 2024 | March 14, 2026 |
| NCT03014440 | No longer available | Study of Cannabidiol for Drug-Resistant Epilepsies | |||
| NCT06334952 | Not yet recruiting | N/A | Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic | June 1, 2024 | April 30, 2027 |
| NCT06387186 | Not yet recruiting | Phase 1 | Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy | April 2024 | March 31, 2025 |
| NCT06366009 | Not yet recruiting | Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy With EEG Extended With Intra-auricular Electrodes | April 8, 2024 | July 31, 2024 | |
| NCT05527093 | Not yet recruiting | N/A | Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy | March 1, 2024 | January 1, 2028 |
| NCT05555537 | Not yet recruiting | MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy | November 1, 2022 | November 1, 2024 | |
| NCT04601974 | Not yet recruiting | Phase 1/Phase 2 | Lentiviral Gene Therapy for Epilepsy | September 2024 | September 2032 |
| NCT06340802 | Not yet recruiting | N/A | A First in hUman Study for Resistant Epilepsy With the Vagus Nerve stimulatiOn Device by syneRgia medicAl | June 2024 | December 2026 |
| NCT04935567 | Not yet recruiting | N/A | PRediction of Vagal Nerve Stimulation EfficaCy In Drug-reSistant Epilepsy | December 1, 2021 | December 31, 2026 |
| NCT06388707 | Not yet recruiting | Phase 1/Phase 2 | A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy | August 1, 2024 | December 31, 2025 |
| NCT06292494 | Recruiting | N/A | Focused Ultrasound for Drug-resistant Epilepsy | January 1, 2024 | December 31, 2027 |
| NCT06309251 | Recruiting | Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients | March 1, 2022 | May 31, 2026 | |
| NCT06432907 | Recruiting | N/A | StereoEEG Motor Neuronal Potentials Decoding | June 6, 2024 | December 25, 2026 |
| NCT03268824 | Recruiting | Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain | December 19, 2017 | October 2024 | |
| NCT03868293 | Recruiting | N/A | Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial | February 7, 2019 | November 9, 2025 |
| NCT04126369 | Recruiting | N/A | Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy. | January 20, 2020 | September 20, 2027 |
| NCT04714996 | Recruiting | Phase 2 | Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy | October 30, 2020 | December 2023 |
| NCT04839601 | Recruiting | N/A | RNS System RESPONSE Study | October 27, 2021 | December 31, 2027 |
| NCT04999046 | Recruiting | N/A | NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy | September 1, 2021 | June 2024 |
| NCT05019885 | Recruiting | Phase 2 | The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy | August 26, 2022 | July 2024 |
| NCT05234411 | Recruiting | Ketonemia Through Menstrual Cycle | July 1, 2020 | December 31, 2023 | |
| NCT05393518 | Recruiting | N/A | Electroclinical Correlation of Anxiety | October 11, 2022 | October 11, 2024 |
| NCT05459090 | Recruiting | Functional Study of Inhibitory Neurotransmission in the Human Epileptic Brain. | July 29, 2022 | July 31, 2027 | |
| NCT05485558 | Recruiting | Phase 2 | the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy | September 15, 2022 | May 1, 2026 |
| NCT05539287 | Recruiting | Phase 2 | Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy | September 25, 2022 | January 2025 |
| NCT05670847 | Recruiting | Phase 2/Phase 3 | Exogenous Ketone Esters for Drug Resistant Epilepsy | January 10, 2023 | July 1, 2024 |
| NCT05697614 | Recruiting | Phase 4 | The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children | March 1, 2023 | June 30, 2023 |
| NCT05928598 | Recruiting | N/A | Goals for Epilepsy Clinic Visits Trial | September 27, 2023 | January 1, 2027 |
| NCT05947656 | Recruiting | N/A | Evaluation of the NaviFUS System in Drug Resistant Epilepsy | October 2, 2023 | May 2025 |
| NCT05951244 | Recruiting | N/A | Cathodal Transcranial Direct Current Stimulation in Patients With Drug-resistant Focal Epilepsy | April 3, 2023 | April 2025 |
| NCT05997758 | Recruiting | Investigating Surprise Signals in the Anterior Insula | January 15, 2024 | December 2025 | |
| NCT06053281 | Recruiting | Early Phase 1 | The Role of Vitamin D in Neuroinflammatory on Drug Resistant Epilepsy | January 19, 2024 | July 1, 2025 |
| NCT06059157 | Recruiting | N/A | Epileptogenic Network Visualisation With Advanced MRI | October 25, 2023 | October 2029 |
| NCT06075485 | Recruiting | Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance | January 15, 2024 | June 2026 | |
| NCT03808935 | Terminated | Phase 3 | Cannabis Extract in Refractory Epilepsy Study | January 10, 2019 | March 15, 2020 |
| NCT04553354 | Unknown status | Cortical Resections in Drug Resistant Epilepsy | September 10, 2020 | November 10, 2022 | |
| NCT04705298 | Unknown status | Phase 4 | Role of the Gut Microbiota in Pediatric Epilepsy | June 1, 2021 | September 1, 2022 |
| NCT03475225 | Unknown status | Phase 3 | Vitamine D in Drug Resistant Epilepsy | April 2018 | April 2020 |
| NCT03464487 | Unknown status | N/A | Comparison Between Efficacy of Daily and Intermittent Low Glycemic Index Therapy Diet | February 15, 2018 | January 2019 |
| NCT02708030 | Unknown status | N/A | Dietary Therapy In Epilepsy Treatment (DIET-Trial): A Randomised Non Inferiority Trial Comparing KD, MAD & LGIT for Drug Resistant Epilepsy | April 2016 | September 2017 |
| NCT03764956 | Unknown status | Phase 4 | Comparison of Efficacy of LGIT and MAD Among Children With Drug Resistant Epilepsy | December 26, 2018 | December 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000069279